Babi Das

Babi Das has a strong background in clinical operations, with extensive experience in various leadership roles. Since 2023, Babi has been working as a Senior Director of Clinical Operations at REVOLUTION Medicines. Prior to that, Babi served as the Executive Director of Clinical Operations at Shasqi from 2022 to 2023. Babi also worked as the Senior Director of Clinical Development at Usona Institute from 2021 to 2022. Earlier in their career, Babi held positions such as Director of Clinical Operations at BioMarin Pharmaceutical Inc. from 2018 to 2020, Director of Clinical Operations at Portola Pharmaceuticals from 2017 to 2018, and Associate Director of Clinical Operations at Medivation from 2016 to 2017. Babi's work experience also includes serving as an Associate Director of Clinical Operations at Onyx Pharmaceuticals, Inc., an Amgen subsidiary, from 2013 to 2015.

Babi Das's education history includes a Master of Public Health (MPH) degree in Public Health Education and Promotion from Loma Linda University. They also completed a certificate program in the Minority Training Program in Cancer Control Research at the University of California, San Francisco. Additionally, Babi earned a Bachelor's Degree in Molecular Biology from the University of California, Santa Cruz. The specific start and end years for each educational experience are not provided.